Joshua Foukas Sells 6,531 Shares of USANA Health Sciences, Inc. (USNA) Stock
USANA Health Sciences, Inc. (NYSE:USNA) insider Joshua Foukas sold 6,531 shares of the company’s stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $125.79, for a total transaction of $821,534.49. Following the sale, the insider now directly owns 2,348 shares of the company’s stock, valued at $295,354.92. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Shares of USANA Health Sciences stock opened at $123.50 on Friday. USANA Health Sciences, Inc. has a twelve month low of $55.50 and a twelve month high of $137.95. The firm has a market cap of $3.05 billion, a P/E ratio of 30.42 and a beta of 0.64.
USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, July 24th. The company reported $1.36 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.25. The company had revenue of $301.50 million during the quarter, compared to analysts’ expectations of $278.41 million. USANA Health Sciences had a net margin of 7.16% and a return on equity of 29.50%. The firm’s revenue for the quarter was up 17.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.98 EPS. analysts anticipate that USANA Health Sciences, Inc. will post 4.9 earnings per share for the current year.
Large investors have recently bought and sold shares of the business. Meeder Asset Management Inc. boosted its position in USANA Health Sciences by 675.1% in the 2nd quarter. Meeder Asset Management Inc. now owns 4,914 shares of the company’s stock valued at $567,000 after buying an additional 4,280 shares during the last quarter. Amalgamated Bank purchased a new position in USANA Health Sciences in the 2nd quarter valued at about $223,000. Dupont Capital Management Corp purchased a new position in USANA Health Sciences in the 2nd quarter valued at about $2,263,000. Seizert Capital Partners LLC purchased a new position in USANA Health Sciences in the 1st quarter valued at about $1,913,000. Finally, Engineers Gate Manager LP purchased a new position in USANA Health Sciences in the 2nd quarter valued at about $1,343,000. 56.38% of the stock is owned by institutional investors.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Recommended Story: What kind of dividend yield to CEF’s pay?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.